The reaffirmation of the Outperform rating and maintenance of the $454 price target by Wedbush analyst David Nierengarten indicates a positive outlook for argenx's stock. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's performance.